Insulet Corporation Logo

Insulet Corporation (GOV)

FSX

Currency in EUR
124.55
-2.30 (-1.81%)

Real-time Data

06:00 AM

Day's Range

124.55
128.90

52 wk Range

112.45
304.00

Overview - GOV - Insulet Corporation

Key Statistics

Valuation

Enterprise Value

7.88B

P/E (Trailing)

‪27.75‬

P/E (Forward)

‪81.83‬

PEG Ratio

‪0.08‬

Price / Sales (TTM)

‪2.88‬

Price / Book

‪7.22‬

EV / EBITDA

‪14.98‬

Profitability

Gross Margin

‪70.17%‬

Profit Margin

‪12.29%‬

Operating Margin

‪16.17%‬

Return on Assets

‪9.71%‬

Return on Equity

‪26.01%‬

Ownership

Shares Outstanding

69.35M

Float

69.06M

Held by Insiders

‪0.32%‬

Held by Institutions

‪107.08%‬

Price stats

Beta

‪1.09‬

50-Day Avg

‪134.26‬

200-Day Avg

‪183.94‬

Dividends

Payout Ratio

‪0.00%‬

Market Cap - GOV - Insulet Corporation

Peers - GOV - Insulet Corporation

Peer Comparison

Compared with companies in Medical Devices listed on FSX.

Profile Summary - GOV - Insulet Corporation

About

Insulet Corporation is a medical device company specializing in insulin delivery technologies for people living with insulin‑dependent diabetes. The company focuses on its Omnipod platform, a family of tubeless, wearable, pod-based insulin management systems designed to provide continuous subcutaneous insulin infusion…

SectorHealthcare
IndustryMedical Devices
Employees5.40K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.